Author:
Vergínia Campagnollo Bueno Ana,Gonçalves Seneda Michelli,Mara Rambo Ângela,Clara Campagnolo Gonçalves Toledo Ana,Cabral de Azevedo Caroline,Viapiana Bossa Adriane
Abstract
Obesity is a chronic disease that affects a large part of the population and can develop several outcomes such as cardiovascular disease, type II diabetes and some types of cancer. As a result, it favors negative aspects both for the individual and for the public power. Faced with this problem, there is a need for new forms of treatment to improve the quality of life of these patients and reduce public spending. New alternatives to traditional medicine are needed for complementary non-drug treatments. Among them is Medicinal Biomagnetism (MB), a technique developed by Dr. Isaac Goiz Durán, which aims to promote body homeostasis using medium intensity magnets. It is believed that this tool can act positively in the control management, and improvement of fluid retention in the body in obese individuals. Objective: This study aims to present and compile the MB 3D Protocol for the treatment of obesity with the published evidence on Static Magnetic Fields (SMFs) applied in obesity. Materials and Methods: Qualitative and exploratory descriptive literature review. Results: Some studies were found that demonstrated that MB therapy can be beneficial for the treatment of obesity. The 3D Protocol has therapeutic potential to produce positive effects, being able to balance the body’s homeostasis by helping to regulate metabolism. Conclusion: Treatments with SMFs have beneficial effects on several aspects of obesity, which supports future studies that evaluate the results of applying the 3D Protocol in this area.
Reference43 articles.
1. Claro RM, Monteiro CA, França GVA, Oliveira PPV, Gouvêa ECDP, Silva LES et al. Brasília DF Secretaria de Vigilância e Saúde. Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico. Brasília. 2021.
2. Alves PHR, Corrêa CR. Relação entre Resposta Imune Inata do Receptor Toll-Like-4 (TLR-4) e o Processo Fisiopatológico da Cardiomiopatia da Obesidade. Arquivos Brasileiros de Cardiologia. Botucatu. 2021; 117 (1): 91-99. doi: 10.36660/abc.20190788.
3. The World Health Organization [homepage na internet]. Obesity and overweight [acesso em 23 oct 2022]. Genebra. 2021. Disponível em: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
4. Chew NWS, Kong G, Venisha S, Chin YH, Han NC, Muthiah M et al. Long-Term Prognosis of Acute Myocardial Infarction Associated with Metabolic Health and Obesity Status. Endocrine Practice. [place unknown]. 2022; 30 (5): 802-810. doi: 10.1016/j.eprac.2022.05.007.
5. Nchidzi N, Letamo G, Keetile M. Prevalence of and factors associated with hypertension, diabetes, stroke and heart attack multimorbidity in Botswana: Evidence from STEPS 2014 survey. [place unknown]. 2022; 24 (3): 1-16.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献